Literature DB >> 22179599

Spinal anesthesia for cesarean section in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.

Torsten Richter1, Karl-Anton Langer, Thea Koch.   

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an inflammatory disorder of the peripheral nervous system with progressive or relapsing signs in more than one limb, ending in prolonged periods of disability. There are no guidelines for anesthesia in this uncommon paralyzing disease. This report features a 19-year-old woman with CIDP scheduled for an elective cesarean section who had prolonged recovery of motor function after the administration of spinal anesthesia. Although a partial neural block in both feet persisted for 1 day, we conclude that spinal anesthesia is acceptable for cesarean delivery in CIDP-patients when reasonable precautions have been taken.

Entities:  

Mesh:

Year:  2011        PMID: 22179599     DOI: 10.1007/s00540-011-1296-z

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  23 in total

1.  The prolonged effect of a muscle relaxant in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  K Hara; K Minami; K Takamoto; M Shiraishi; T Sata
Journal:  Anesth Analg       Date:  2000-01       Impact factor: 5.108

2.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

3.  Diffuse spinal and intercostal nerve involvement in chronic inflammatory demyelinating polyradiculoneuropathy: MRI findings.

Authors:  Berna Oguz; Kader Karli Oguz; Aysenur Cila; Ersin Tan
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

4.  Autonomic dysfunction in the Guillain-Barré syndrome.

Authors:  P Lichtenfeld
Journal:  Am J Med       Date:  1971-06       Impact factor: 4.965

5.  Anaesthesia in the Guillian-Barré syndrome. A case report and recommendations.

Authors:  A Perel; A Reches; J T Davidson
Journal:  Anaesthesia       Date:  1977-03       Impact factor: 6.955

Review 6.  Guillain-Barré syndrome in pregnancy.

Authors:  Louis Yik-Si Chan; Michelle Hang-Yuet Tsui; Tse Ngong Leung
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

7.  Cardiac arrest after succinylcholine administration in a pregnant patient recovered from Guillain-Barré syndrome.

Authors:  J M Feldman
Journal:  Anesthesiology       Date:  1990-05       Impact factor: 7.892

8.  Chronic Inflammatory Demyelinating Polyneuropathy.

Authors:  Jonathan S. Katz; David S. Saperstein
Journal:  Curr Treat Options Neurol       Date:  2003-09       Impact factor: 3.598

9.  Guillain-Barré syndrome after epidural anesthesia: direct nerve root damage may trigger disease.

Authors:  I Steiner; Z Argov; C Cahan; O Abramsky
Journal:  Neurology       Date:  1985-10       Impact factor: 9.910

10.  Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  R Press; M Pashenkov; J P Jin; H Link
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

View more
  3 in total

1.  Intrathecal Dexmedetomidine for Anaesthetic Management of a Patient with Chronic Inflammatory Demyelinating Polyneuropathy.

Authors:  S Bala Bhaskar; D Srinivasalu
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Anesthetic management of a patient with chronic inflammatory demyelinating polyneuropathy by combination of total intravenous and regional anesthesia.

Authors:  Daiki Takekawa; Kishiko Nakai; Hirotaka Kinoshita; Junichi Saito; Masato Kitayama; Tetsuya Kushikata; Kazuyoshi Hirota
Journal:  JA Clin Rep       Date:  2019-03-09

3.  Anesthetic Management of a Patient With Distal Acquired Demyelinating Symmetric (DADS) Neuropathy Under General Anesthesia.

Authors:  Stefen P Roth; Thomas Gemma; Tracy Dovich; Anthony Candella
Journal:  Cureus       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.